Search research articles
Contact Us
Filters
Showing results (251-260 of 336) with videos related to
Page
of 34
Sort By:
Cancer Medicine
|
February 21, 2025
Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience
Mimma Rizzo, Franco Morelli, Yüksel Ürün, et al.
Targeted Oncology
|
August 6, 2024
Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project
Alessandro Rizzo, Fernando Sabino Marques Monteiro, Yüksel Ürün, et al.
Cancer Immunology, Immunotherapy : CII
|
August 28, 2023
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study
Melissa Bersanelli, Alessio Cortellini, Alessandro Leonetti, et al.
Cancer Immunology, Immunotherapy : CII
|
January 3, 2025
First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study
Giandomenico Roviello, Javier Molina-Cerrillo, Francesco Massari, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 2024
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy
Andrea De Giglio, Alessandro Leonetti, Francesca Comito, et al.
The Oncologist
|
October 5, 2023
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study
Federica Pecci, Luca Cantini, Valeria Cognigni, et al.
Scientific Reports
|
March 12, 2026
Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumors
Giulia Bruschi, Francesco Paoloni, Federica Pecci, et al.
Future Oncology (London, England)
|
April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Future Oncology (London, England)
|
June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
International Journal of Cancer
|
November 4, 2025
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)
Javier Molina-Cerrillo, Giandomenico Roviello, Maria T Bourlon, et al.
Page
of 34
Search research articles
Search
Showing results (251-260 of 336) with videos related to
Sort By:
Page
of 34
Cancer Medicine
|
February 21, 2025
Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience
Mimma Rizzo, Franco Morelli, Yüksel Ürün, et al.
Targeted Oncology
|
August 6, 2024
Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project
Alessandro Rizzo, Fernando Sabino Marques Monteiro, Yüksel Ürün, et al.
Cancer Immunology, Immunotherapy : CII
|
August 28, 2023
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study
Melissa Bersanelli, Alessio Cortellini, Alessandro Leonetti, et al.
Cancer Immunology, Immunotherapy : CII
|
January 3, 2025
First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study
Giandomenico Roviello, Javier Molina-Cerrillo, Francesco Massari, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 2024
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy
Andrea De Giglio, Alessandro Leonetti, Francesca Comito, et al.
The Oncologist
|
October 5, 2023
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study
Federica Pecci, Luca Cantini, Valeria Cognigni, et al.
Scientific Reports
|
March 12, 2026
Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumors
Giulia Bruschi, Francesco Paoloni, Federica Pecci, et al.
Future Oncology (London, England)
|
April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Future Oncology (London, England)
|
June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)
Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
International Journal of Cancer
|
November 4, 2025
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)
Javier Molina-Cerrillo, Giandomenico Roviello, Maria T Bourlon, et al.
Page
of 34